State of Wyoming trimmed its holdings in Globe Life Inc. (NYSE:GL - Free Report) by 34.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,727 shares of the company's stock after selling 2,486 shares during the quarter. State of Wyoming's holdings in Globe Life were worth $623,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in GL. Kovitz Investment Group Partners LLC bought a new position in shares of Globe Life in the fourth quarter valued at about $391,000. Susquehanna Fundamental Investments LLC bought a new position in shares of Globe Life in the fourth quarter valued at about $1,194,000. The Manufacturers Life Insurance Company raised its holdings in shares of Globe Life by 1.5% in the fourth quarter. The Manufacturers Life Insurance Company now owns 70,666 shares of the company's stock valued at $7,881,000 after buying an additional 1,019 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Globe Life by 3.3% in the fourth quarter. Northern Trust Corp now owns 817,489 shares of the company's stock valued at $91,166,000 after buying an additional 26,398 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC raised its holdings in shares of Globe Life by 62.0% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 10,761 shares of the company's stock valued at $1,200,000 after buying an additional 4,118 shares during the last quarter. 81.61% of the stock is owned by institutional investors.
Insiders Place Their Bets
In related news, EVP Michael Clay Majors sold 10,000 shares of the stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $137.41, for a total transaction of $1,374,100.00. Following the completion of the sale, the executive vice president directly owned 47,066 shares of the company's stock, valued at approximately $6,467,339.06. This represents a 17.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Thomas Peter Kalmbach sold 28,952 shares of the stock in a transaction that occurred on Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total value of $4,081,363.44. Following the sale, the chief financial officer directly owned 30,665 shares of the company's stock, valued at approximately $4,322,845.05. The trade was a 48.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 84,722 shares of company stock valued at $11,733,793 in the last quarter. 1.97% of the stock is owned by company insiders.
Globe Life Trading Down 0.1%
Shares of GL stock traded down $0.12 on Tuesday, reaching $139.83. The company had a trading volume of 511,704 shares, compared to its average volume of 648,164. The company has a 50-day moving average of $131.18 and a 200-day moving average of $125.66. Globe Life Inc. has a 12 month low of $99.04 and a 12 month high of $144.00. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43. The stock has a market cap of $11.33 billion, a PE ratio of 11.18 and a beta of 0.56.
Globe Life (NYSE:GL - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.25 by $0.02. Globe Life had a return on equity of 21.24% and a net margin of 18.11%.The business had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same period in the prior year, the business earned $2.97 EPS. Globe Life's revenue for the quarter was up 2.9% compared to the same quarter last year. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. On average, equities analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life's dividend payout ratio is presently 8.63%.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the company. Cfra Research raised Globe Life to a "moderate buy" rating in a report on Friday, July 25th. Truist Financial started coverage on Globe Life in a report on Tuesday, July 15th. They set a "buy" rating and a $150.00 price objective for the company. BMO Capital Markets reissued a "market perform" rating and set a $149.00 price objective (up from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Keefe, Bruyette & Woods boosted their price objective on Globe Life from $145.00 to $155.00 and gave the stock an "outperform" rating in a report on Monday, July 28th. Finally, Wells Fargo & Company boosted their price objective on Globe Life from $144.00 to $150.00 and gave the stock an "overweight" rating in a report on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $152.45.
Read Our Latest Report on GL
About Globe Life
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.